BPC-157 10mg A 15-amino acid pentadecapeptide derived from human gastric juice, studied for its remarkable capacity to accelerate healing across musculoskeletal, gastrointestinal, and neural tissues
FOXO4-DRI is among the highest-risk research peptides from an evidence-to-risk standpoint: it has never been tested in humans, no human pharmacokinetic data exists, and as a senolytic it carries theoretical risks specific to its mechanism
Vitamin B12 injections can contain cobalt, which can also cause an allergic reaction
Poor sleep impairs healing, increases pain sensitivity, and prolongs recovery
Research has suggested that intravenous glutathione or N-acetylcysteine (the precursor to glutathione) can significantly reduce homocysteine levels, with one animal study showing that glutathione reduced homocysteine by 51%